CORT · Categories · Coverage
CORT - Analyst coverage initiated
Corcept Therapeutics Incorporated (CORT) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for CORT
- UBS initiated coverage on Corcept TherapeuticsUBS initiated coverage of Corcept Therapeutics with a rating of Neutral
- Wolfe Research initiated coverage on Corcept TherapeuticsWolfe Research initiated coverage of Corcept Therapeutics with a rating of Peer Perform
- SVB Securities initiated coverage on Corcept Therapeutics with a new price targetSVB Securities initiated coverage of Corcept Therapeutics with a rating of Market Perform and set a new price target of $25.00
- Piper Sandler initiated coverage on Corcept Therapeutics with a new price targetPiper Sandler initiated coverage of Corcept Therapeutics with a rating of Overweight and set a new price target of $27.00
- Canaccord Genuity initiated coverage on Corcept Therapeutics with a new price targetCanaccord Genuity initiated coverage of Corcept Therapeutics with a rating of Buy and set a new price target of $30.00
- Truist initiated coverage on Corcept Therapeutics with a new price targetTruist initiated coverage of Corcept Therapeutics with a rating of Buy and set a new price target of $30.00